MA24062A1 - Heteroatome comprenant des cyclopentano-pyridile oxazolidinones - Google Patents

Heteroatome comprenant des cyclopentano-pyridile oxazolidinones

Info

Publication number: MA24062A1
Authority: MA; Morocco
Prior art keywords: pyridile; cyclopentano; heteroatome; oxazolidinones; pyridile oxazolidinones
Prior art date: 1996-01-18

Application number

MA24463A

Other languages

English (en)

Inventor

Stolle Andreas

Bartel Stephan

Ruppelt Martin

Kroll Hein-Peter

Endermann Rainer

Habich Dieter

Guarnieri Walter

Riedl Bernd

Original Assignee

Bayer Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-01-18

Filing date

1997-01-14

Publication date

1997-10-01

1997-01-14 Application filed by Bayer Ag filed Critical Bayer Ag

1997-10-01 Publication of MA24062A1 publication Critical patent/MA24062A1/fr

Links

IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Oncology (AREA)
Animal Behavior & Ethology (AREA)
Communicable Diseases (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Plural Heterocyclic Compounds (AREA)

MA24463A 1996-01-18 1997-01-14 Heteroatome comprenant des cyclopentano-pyridile oxazolidinones MA24062A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19601627A DE19601627A1 (de)	1996-01-18	1996-01-18	Heteroatomhaltige Cyclopentanopyridyl-Oxazolidinone

Publications (1)

Publication Number	Publication Date
MA24062A1 true MA24062A1 (fr)	1997-10-01

Family

ID=7783042

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA24463A MA24062A1 (fr)	1996-01-18	1997-01-14	Heteroatome comprenant des cyclopentano-pyridile oxazolidinones

Country Status (21)

Country	Link
US (1)	US5869659A (fr)
EP (1)	EP0785201A1 (fr)
JP (1)	JPH09202787A (fr)
KR (1)	KR970059170A (fr)
AU (1)	AU1012397A (fr)
BG (1)	BG101139A (fr)
BR (1)	BR9700716A (fr)
CA (1)	CA2195177A1 (fr)
CZ (1)	CZ15897A3 (fr)
DE (1)	DE19601627A1 (fr)
EE (1)	EE9700020A (fr)
HU (1)	HU9700152D0 (fr)
IL (1)	IL120016A0 (fr)
MA (1)	MA24062A1 (fr)
NO (1)	NO970210L (fr)
PL (1)	PL317985A1 (fr)
SG (1)	SG50001A1 (fr)
SK (1)	SK6997A3 (fr)
TN (1)	TNSN97010A1 (fr)
TR (1)	TR199700039A2 (fr)
ZA (1)	ZA97393B (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR9907183A (pt)	1998-01-23	2003-06-10	Versicor Inc	Colet neas combinatórias de oxazolidinona, composições e processos de preparação
US6562844B2 (en)	1998-01-23	2003-05-13	Pharmacia & Upjohn Company	Oxazolidinone combinatorial libraries, compositions and methods of preparation
US7002020B1 (en)	1998-01-23	2006-02-21	Pharmacia & Upjohn Company	Oxazolidinone combinatorial libraries, compositions and methods of preparation
WO1999064417A2 (fr)	1998-06-05	1999-12-16	Astrazeneca Ab	Composes chimiques
WO2001009107A1 (fr)	1999-07-28	2001-02-08	Pharmacia & Upjohn Company	Oxazolidinones et leur utilisation comme anti-infectieux
GB9928568D0 (en)	1999-12-03	2000-02-02	Zeneca Ltd	Chemical compounds
US6514529B2 (en)	2000-03-22	2003-02-04	Pharmacia & Upjohn Company	Oxazolidinone tablet formulation
MY127336A (en)	2000-03-22	2006-11-30	Upjohn Co	Container for linezolid iv solution
GB0009803D0 (en) *	2000-04-25	2000-06-07	Astrazeneca Ab	Chemical compounds
AU2001272961A1 (en)	2000-06-30	2002-01-14	Pharmacia & Upjohn Company	Compositions for treating bacterial infections containing oxazolidinone compound, sulbactam and an ampicillin
US6423844B1 (en)	2001-06-06	2002-07-23	The United States Of America As Represented By The Secretary Of The Navy	Process for making 1,2,4-triazolo[4,3-a][1,3,5]triazine-3,5,7-triamine
US7141588B2 (en) *	2002-02-25	2006-11-28	Pfizer, Inc.	N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
AR038536A1 (es) *	2002-02-25	2005-01-19	Upjohn Co	N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
DE60304360T2 (de) *	2002-08-12	2006-11-16	Pharmacia & Upjohn Co. Llc, Kalamazoo	N-aryl-2-oxazolidinone und deren derivate
ATE344036T1 (de) *	2002-11-21	2006-11-15	Pharmacia & Upjohn Co Llc	N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinon-5- carbonsäureamid-derivate und verwandte verbindungen als antibakterielle mittel
CA2515269A1 (fr) *	2003-02-07	2004-08-19	Warner-Lambert Company Llc	Derives d'oxazolidinone n-substitues par un noyau bicyclique, utilises comme agents antibacteriens
BRPI0407252A (pt) *	2003-02-07	2006-01-31	Warner Lambert Co	Agentes antibacterianos.
US7012088B2 (en) *	2003-02-24	2006-03-14	Pharmacia & Upjohn Company	Indolone oxazolidinones and derivatives thereof
US20040204463A1 (en) *	2003-04-01	2004-10-14	Harris Christina Renee	N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
US7304050B2 (en) *	2003-09-16	2007-12-04	Pfizer Inc.	Antibacterial agents
WO2005082900A2 (fr) *	2004-01-28	2005-09-09	Pharmacia & Upjohn Company Llc	Amidoxines d'oxazolidinone utilisees en tant qu'agents antibacteriens
EP1781642A1 (fr) *	2004-08-06	2007-05-09	Pharmacia & Upjohn Company LLC	Oxazolidinones contenant des oxindoles en tant qu'agents antibacteriens
MX337906B (es) *	2006-10-19	2016-03-28	Signal Pharm Llc	Compuestos de heteroarilo, composiciones de los mismos, y su uso como inhibidores de proteina cinasas.
US8110578B2 (en)	2008-10-27	2012-02-07	Signal Pharmaceuticals, Llc	Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway
SG10201500511TA (en)	2009-10-26	2015-03-30	Signal Pharm Llc	Methods Of Synthesis And Purification Of Heteroaryl Compounds
PH12014500869A1 (en)	2011-10-19	2014-06-30	Signal Pharm Llc	Treatment of cancer with tor kinase inhibitors
KR102040997B1 (ko)	2011-12-02	2019-11-27	시그날 파마소티칼 엘엘씨	7-(6-(2-히드록시프로판-2-일)피리딘-3-일)-1-((트랜스)-4-메톡시시클로헥실)-3,4-디히드로피라지노[2,3-b]피라진-2(1H)-온, 그의 고체 형태의 제약 조성물 및 그의 사용 방법
EP2817029B1 (fr)	2012-02-24	2019-07-10	Signal Pharmaceuticals, LLC	Procédés de traitement du cancer du poumon non à petites cellules à l'aide d'une thérapie combinée d'inhibiteur de kinase
AU2013203714B2 (en)	2012-10-18	2015-12-03	Signal Pharmaceuticals, Llc	Inhibition of phosphorylation of PRAS40, GSK3-beta or P70S6K1 as a marker for TOR kinase inhibitory activity
PE20151995A1 (es)	2013-01-16	2016-01-13	Signal Pharm Llc	Compuestos sustituidos de pirrolopirimidina, composiciones de los mismos, y metodos de tratamiento con los mismos
US9505764B2 (en)	2013-04-17	2016-11-29	Signal Pharmaceuticals, Llc	Treatment of cancer with dihydropyrazino-pyrazines
US9630966B2 (en)	2013-04-17	2017-04-25	Signal Pharmaceuticals, Llc	Treatment of cancer with dihydropyrazino-pyrazines
WO2014172436A1 (fr)	2013-04-17	2014-10-23	Signal Pharmaceuticals, Llc	Polythérapie comprenant un inhibiteur de kinase tor et un composé de quinazolinone substitué en 5 pour le traitement du cancer
CA2908742C (fr)	2013-04-17	2021-06-01	Signal Pharmaceuticals, Llc	Polytherapie comprenant un inhibiteur de la kinase tor et un analogue de la cytidine pour le traitement du cancer
CN105377299B (zh)	2013-04-17	2018-06-12	西格诺药品有限公司	用于治疗前列腺癌的包含二氢吡嗪并-吡嗪化合物和雄激素受体拮抗剂的组合疗法
CA2909579A1 (fr)	2013-04-17	2014-10-23	Signal Pharmaceuticals, Llc	Therapie combinee comprenant un inhibiteur de la kinase tor et du n-(3-(5-fluoro-2-(4-(2-methoxyethoxy)phenylamino)pyrimidin-4-ylamino)phenyl)acrylamide pour le traitement d'un cancer
CA2909629C (fr)	2013-04-17	2022-12-13	Signal Pharmaceuticals, Llc	Formulations pharmaceutiques, procedes, formes solides et methodes d'utilisation associes a la 1-ethyl-7-(2-methyl-6-(1h-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1h)-one
NZ629486A (en)	2013-05-29	2017-11-24	Signal Pharm Llc	Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1h)-one, a solid form thereof and methods of their use
US9512129B2 (en)	2014-04-16	2016-12-06	Signal Pharmaceuticals, Llc	Solid forms comprising 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one and a coformer
WO2015160882A1 (fr)	2014-04-16	2015-10-22	Signal Pharmaceuticals, Llc	Formes solides comprenant de la 7-(6- (2-hydroxypropan-2-yl) pyridin-3-yl)-1-(trans)-4-méthoxycyclohexyl)-3, 4-dihydropyrazino[2,3-b] pyrazin-2(1h)-one, et un co-formeur, leurs compositions et leurs procédés d'utilisation
NZ714742A (en)	2014-04-16	2017-04-28	Signal Pharm Llc	Solid forms of 1-ethyl-7-(2-methyl-6-(1h-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1h)-one, compositions thereof and methods of their use
ES2823756T3 (es)	2014-04-16	2021-05-10	Signal Pharm Llc	Métodos para tratar el cáncer usando terapia de combinación de inhibidores de quinasa TOR
WO2016010886A1 (fr)	2014-07-14	2016-01-21	Signal Pharmaceuticals, Llc	Méthodes de traitement d'un cancer à l'aide de composés de pyrrolopyrimidine substitués, compositions de ceux-ci
NZ629796A (en)	2014-07-14	2015-12-24	Signal Pharm Llc	Amorphous form of 4-((4-(cyclopentyloxy)-5-(2-methylbenzo[d]oxazol-6-yl)-7h-pyrrolo[2,3-d]pyrimidin-2-yl)amino)-3-methoxy-n-methylbenzamide, compositions thereof and methods of their use
TWI787284B (zh)	2017-06-22	2022-12-21	美商西建公司	以b型肝炎病毒感染表徵之肝細胞癌之治療

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4705799A (en) *	1983-06-07	1987-11-10	E. I. Du Pont De Nemours And Company	Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents
US4921869A (en) *	1987-10-09	1990-05-01	E. I. Du Pont De Nemours And Company	Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4985429A (en) *	1987-10-09	1991-01-15	E. I. Du Pont De Nemours And Company	Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4801600A (en) *	1987-10-09	1989-01-31	E. I. Du Pont De Nemours And Company	Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4965268A (en) *	1987-10-09	1990-10-23	E. I. Du Pont De Nemours And Company	Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4942183A (en) *	1987-10-16	1990-07-17	E. I. Du Pont De Nemours And Company	Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
US5254577A (en) *	1988-07-29	1993-10-19	The Du Pont Merck Pharmaceutical Company	Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
JP2865211B2 (ja)	1988-09-15	1999-03-08	ファルマシア・アンド・アップジョン・カンパニー	５’―インドリニル―５β―アミドメチルオキサゾリジン―２―オン類、３―（縮合環置換）フェニル―５β―アミドメチルオキサゾリジン―２―オン類および３―（窒素原子置換）フェニル―５β―アミドメチルオキサゾリジン―２―オン類
US5164510A (en) *	1988-09-15	1992-11-17	The Upjohn Company	5'Indolinyl-5β-amidomethyloxazolidin-2-ones
JP2679745B2 (ja) *	1989-06-29	1997-11-19	明治製菓株式会社	アゾール誘導体及びそれらを有効成分とする抗潰瘍剤
JP2669579B2 (ja)	1991-10-23	1997-10-29	エーザイ株式会社	オキサゾリドン誘導体
DE4332384A1 (de) *	1993-09-23	1995-03-30	Merck Patent Gmbh	Adhäsionsrezeptor-Antagonisten III
TW286317B (fr)	1993-12-13	1996-09-21	Hoffmann La Roche
DE4425612A1 (de) *	1994-07-20	1996-04-04	Bayer Ag	6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone

1996
- 1996-01-18 DE DE19601627A patent/DE19601627A1/de not_active Withdrawn
1997
- 1997-01-07 EP EP97100114A patent/EP0785201A1/fr not_active Withdrawn
- 1997-01-10 AU AU10123/97A patent/AU1012397A/en not_active Abandoned
- 1997-01-13 US US08/785,145 patent/US5869659A/en not_active Expired - Fee Related
- 1997-01-14 MA MA24463A patent/MA24062A1/fr unknown
- 1997-01-15 CA CA002195177A patent/CA2195177A1/fr not_active Abandoned
- 1997-01-15 SG SG1997000082A patent/SG50001A1/en unknown
- 1997-01-15 TN TNTNSN97010A patent/TNSN97010A1/fr unknown
- 1997-01-16 JP JP9017765A patent/JPH09202787A/ja active Pending
- 1997-01-16 EE EE9700020A patent/EE9700020A/xx unknown
- 1997-01-16 BG BG101139A patent/BG101139A/xx unknown
- 1997-01-16 IL IL12001697A patent/IL120016A0/xx unknown
- 1997-01-16 PL PL97317985A patent/PL317985A1/xx unknown
- 1997-01-17 CZ CZ97158A patent/CZ15897A3/cs unknown
- 1997-01-17 HU HU9700152A patent/HU9700152D0/hu unknown
- 1997-01-17 BR BR9700716A patent/BR9700716A/pt unknown
- 1997-01-17 ZA ZA97393A patent/ZA97393B/xx unknown
- 1997-01-17 NO NO970210A patent/NO970210L/no unknown
- 1997-01-17 TR TR97/00039A patent/TR199700039A2/xx unknown
- 1997-01-17 SK SK69-97A patent/SK6997A3/sk unknown
- 1997-01-17 KR KR1019970001266A patent/KR970059170A/ko not_active Withdrawn

Also Published As

Publication number	Publication date
IL120016A0 (en)	1997-04-15
CA2195177A1 (fr)	1997-07-19
BG101139A (en)	1998-04-30
TR199700039A2 (tr)	1997-08-21
JPH09202787A (ja)	1997-08-05
AU1012397A (en)	1997-07-24
HU9700152D0 (en)	1997-03-28
PL317985A1 (en)	1997-07-21
BR9700716A (pt)	1998-10-06
TNSN97010A1 (fr)	2005-03-15
SG50001A1 (en)	1998-06-15
EP0785201A1 (fr)	1997-07-23
NO970210L (no)	1997-07-21
ZA97393B (en)	1997-07-17
US5869659A (en)	1999-02-09
CZ15897A3 (en)	1997-08-13
MX9700388A (es)	1997-07-31
NO970210D0 (no)	1997-01-17
EE9700020A (et)	1997-08-15
SK6997A3 (en)	1997-09-10
DE19601627A1 (de)	1997-07-24
KR970059170A (ko)	1997-08-12

Publication	Publication Date	Title
MA24062A1 (fr)	1997-10-01	Heteroatome comprenant des cyclopentano-pyridile oxazolidinones
FR2746302B1 (fr)	1998-12-24	Compositions cosmetiques comprenant des nanopigments
DE69721098D1 (de)	2003-05-28	Entwicklungsgerät
DE69720097D1 (de)	2003-04-30	Entwicklungsgerät
DE69715313D1 (de)	2002-10-17	Entwicklungsgerät
IT1291486B1 (it)	1999-01-11	Corpo portante.
DK0800783T3 (da)	2001-11-05	Gulvrenseapparat
FI970183A7 (fi)	1997-01-16	Mikrobimenetelmä
ZA981579B (en)	1999-03-17	Oxazolidinones
FR2718478B1 (fr)	1996-07-05	Plinthe démontable.
DE59710679D1 (de)	2003-10-09	Lüfter
EP0665613A3 (fr)	1997-04-02	Assemblage d'un détecteur démontable.
TR199501336A2 (tr)	1996-06-21	Talim tertibati.
FR2746301B1 (fr)	1998-04-30	Compositions cosmetiques comprenant des nanopigments
FI3488U1 (fi)	1998-07-30	Pitolaite
IT237397Y1 (it)	2000-09-13	Elettrodomestico
EP1008101A4 (fr)	2003-03-26	Support cryptographique
DE69709700D1 (de)	2002-02-21	Kontrastmittel
DE59509813D1 (de)	2001-12-13	Substituierte oxazoline
FR2724100B1 (fr)	1997-09-19	Oreiller de soutien.
FR2716348B1 (fr)	1996-05-03	Coiffe réglable.
IT1287807B1 (it)	1998-08-18	Dispositivo di fissaggio di corpo rotante.
FR2721514B1 (fr)	1996-09-06	Compositions thérapeutiques comprenant des 3-phényl-3-hydroxypipéridines.
ES1035520Y (es)	1997-11-16	Almohada compleja.
ITBO940383A0 (it)	1994-08-03	Apparecchio magneto-terapeutico.